These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 7637346)

  • 1. Peritoneal and splenic macrophage functions in the tumor-bearing host.
    Gardner TE; Naama H; Daly JM
    J Surg Res; 1995 Aug; 59(2):305-10. PubMed ID: 7637346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice.
    Bourassa B; Monaghan S; Rittling SR
    Cell Immunol; 2004 Jan; 227(1):1-11. PubMed ID: 15051510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity. Involvement of cell-associated tumor necrosis factor and reactive nitrogen.
    Ayala A; Perrin MM; Wang P; Ertel W; Chaudry IH
    J Immunol; 1991 Dec; 147(12):4147-54. PubMed ID: 1753090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG; Burger CJ; Elgert KD
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-color flow cytometric analysis of the expression of MAC and MHC class II antigens on macrophages during tumor growth.
    Yurochko AD; Burger CJ; Elgert KD
    Cytometry; 1990; 11(6):725-35. PubMed ID: 2200657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of macrophages and lymphocytes by methylglyoxal against tumor cells in the host.
    Bhattacharyya N; Pal A; Patra S; Haldar AK; Roy S; Ray M
    Int Immunopharmacol; 2008 Nov; 8(11):1503-12. PubMed ID: 18617020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
    Young MR; Newby M
    J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide.
    Young MR; Wright MA; Matthews JP; Malik I; Prechel M
    J Immunol; 1996 Mar; 156(5):1916-22. PubMed ID: 8596044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
    Fernandez-Cruz E; Ulich T; Schreiber RD
    J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NO in macrophage dysfunction at early stage after burn injury.
    Luo G; Peng D; Zheng J; Chen X; Wu J; Elster E; Tadaki D
    Burns; 2005 Mar; 31(2):138-44. PubMed ID: 15683683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abundant production of nitric oxide from murine macrophages by direct stimulation of tumor cells.
    Isobe K; Nakashima I
    Biochem Biophys Res Commun; 1993 Apr; 192(2):499-504. PubMed ID: 8484761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of teichoic acid from S. aureus on metabolic activity of macrophages and cytotoxic activity of splenocytes of mice bearing Lewis lung carcinoma.
    Potebnya GP; Skivka LM; Pozur VV; Rudik MP; Senchilo NV; Fedorchuk OG; Khranovska NM
    Exp Oncol; 2008 Sep; 30(3):220-3. PubMed ID: 18806745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
    Fujii T; Igarashi T; Kishimoto S
    J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation in protein-energy malnutrition.
    Redmond HP; Gallagher HJ; Shou J; Daly JM
    Cell Immunol; 1995 Jun; 163(1):80-7. PubMed ID: 7758132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro natural cell-mediated cytotoxicity against Candida albicans: macrophage precursors as effector cells.
    Baccarini M; Bistoni F; Lohmann-Matthes ML
    J Immunol; 1985 Apr; 134(4):2658-65. PubMed ID: 3882833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aging on the tumoricidal functions of murine peritoneal macrophages.
    Khare V; Sodhi A; Singh SM
    Nat Immun; 1996-1997; 15(6):285-94. PubMed ID: 9523280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2.
    Wigginton JM; Kuhns DB; Back TC; Brunda MJ; Wiltrout RH; Cox GW
    Cancer Res; 1996 Mar; 56(5):1131-6. PubMed ID: 8640772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus.
    Rowland RR; Butz EA; Plagemann PG
    J Immunol; 1994 Jun; 152(12):5785-95. PubMed ID: 8207208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.